InvestSMART

Healius Limited (ASX: HLS) - Announcements

- Current share price for HLS : $0.455

ASX company news and announcements for Healius Limited (HLS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Healius Limited (HLS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Healius Limited (HLS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Healius Limited (HLS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$330 Becoming a substantial holder 26 Mar 2024 8:25AM $1.290 $0.455 fallen by 64.73%
$330 Change in substantial holding 22 Mar 2024 3:32PM $1.255 $0.455 fallen by 63.75%
$330 Ceasing to be a substantial holder 20 Mar 2024 6:11PM $1.205 $0.455 fallen by 62.24%
$330 Change of Director's Interest Notice 18 Mar 2024 10:41AM $1.243 $0.455 fallen by 63.38%
$330 Change of Director's Interest Notice 18 Mar 2024 10:40AM $1.240 $0.455 fallen by 63.31%
$330 Application for quotation of securities - HLS 18 Mar 2024 8:47AM $1.260 $0.455 fallen by 63.89%
$330 Change in substantial holding from PPT 8 Mar 2024 4:38PM $1.335 $0.455 fallen by 65.92%
$330 Initial Director's Interest Notice 6 Mar 2024 12:24PM $1.245 $0.455 fallen by 63.45%
$330 Final Director's Interest Notice 6 Mar 2024 12:23PM $1.245 $0.455 fallen by 63.45%
$330 HLS confirms CFO appointment and new Audit Chair 6 Mar 2024 10:15AM $1.240 $0.455 fallen by 63.31%
$330 HLS Strategic Review and CEO Resignation and Appointment 5 Mar 2024 9:15AM $1.125 $0.455 fallen by 59.56%
$330 Change of Director's Interest Notice 4 Mar 2024 10:49AM $1.163 $0.455 fallen by 60.86%
$330 Change in substantial holding from PPT 1 Mar 2024 4:34PM $1.170 $0.455 fallen by 61.11%
$330 Notification regarding unquoted securities - HLS 1 Mar 2024 3:55PM $1.175 $0.455 fallen by 61.28%
$330 Notification regarding unquoted securities - HLS 1 Mar 2024 3:50PM $1.175 $0.455 fallen by 61.28%
$330 Half Year 2024 Results Presentation 27 Feb 2024 9:23AM $1.385 $0.455 fallen by 67.15%
$330 Healius announces 1H 2024 results 27 Feb 2024 9:19AM $1.385 $0.455 fallen by 67.15%
$330 Half Yearly Report and Accounts 27 Feb 2024 9:15AM $1.385 $0.455 fallen by 67.15%
$330 Healius announces Trading Update for FY 2024 21 Feb 2024 9:20AM $1.400 $0.455 fallen by 67.50%
$330 Ceasing to be a substantial holder from MUFG 8 Feb 2024 6:37PM $1.445 $0.455 fallen by 68.51%
$330 Webcast Details for Healius 1H 2024 Results 8 Feb 2024 4:56PM $1.445 $0.455 fallen by 68.51%
$330 Ceasing to be a substantial holder 7 Feb 2024 5:53PM $1.400 $0.455 fallen by 67.50%
$330 Agilex commercial agreement and new Lumus Imaging Clinics 6 Feb 2024 3:13PM $1.393 $0.455 fallen by 67.32%
$330 Change of Director's Interest Notice 31 Jan 2024 3:11PM $1.393 $0.455 fallen by 67.32%
$330 Change in substantial holding from PPT 18 Jan 2024 4:45PM $1.315 $0.455 fallen by 65.40%

201 - 225 of 1030 results

Page 9 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.